Halberd Co. (OTCMKTS:HALB) Short Interest Up 6,783.3% in September

Halberd Co. (OTCMKTS:HALB) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 123,900 shares, a growth of 6,783.3% from the August 31st total of 1,800 shares. Based on an average trading volume of 2,266,100 shares, the short-interest ratio is currently 0.1 days.

Halberd Price Performance

HALB stock opened at $0.01 on Wednesday. The firm’s fifty day moving average is $0.01 and its 200 day moving average is $0.01. Halberd has a 52 week low of $0.00 and a 52 week high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.